ZIONS BANORATION NA ($ZION) posted quarterly earnings results on Monday, October 20th. The company reported earnings of $1.54 per share, beating estimates of $1.50 by $0.04. The company also reported revenue of $872,000,000, beating estimates of $860,478,120 by $11,521,880.
You can see Quiver Quantitative's $ZION stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ZIONS BANORATION NA Insider Trading Activity
ZIONS BANORATION NA insiders have traded $ZION stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ZION stock by insiders over the last 6 months:
- JASON D. ARBUCKLE (SVP - Controller) sold 294 shares for an estimated $13,906
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ZIONS BANORATION NA Hedge Fund Activity
We have seen 234 institutional investors add shares of ZIONS BANORATION NA stock to their portfolio, and 237 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 1,284,395 shares (-85.5%) from their portfolio in Q2 2025, for an estimated $66,711,476
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,282,401 shares (-96.4%) from their portfolio in Q2 2025, for an estimated $66,607,907
- FREESTONE GROVE PARTNERS LP removed 1,007,915 shares (-83.1%) from their portfolio in Q2 2025, for an estimated $52,351,105
- ARTEMIS INVESTMENT MANAGEMENT LLP removed 768,556 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $39,918,798
- ALLIANZ ASSET MANAGEMENT GMBH added 758,855 shares (+168.4%) to their portfolio in Q2 2025, for an estimated $39,414,928
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 616,248 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,007,921
- AQR CAPITAL MANAGEMENT LLC removed 614,432 shares (-21.4%) from their portfolio in Q2 2025, for an estimated $31,913,598
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ZIONS BANORATION NA Congressional Stock Trading
Members of Congress have traded $ZION stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ZION stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ZIONS BANORATION NA Analyst Ratings
Wall Street analysts have issued reports on $ZION in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 10/17/2025
- Evercore ISI Group issued a "Outperform" rating on 09/30/2025
- Cantor Fitzgerald issued a "Overweight" rating on 09/10/2025
- DA Davidson issued a "Buy" rating on 07/22/2025
To track analyst ratings and price targets for ZIONS BANORATION NA, check out Quiver Quantitative's $ZION forecast page.
ZIONS BANORATION NA Price Targets
Multiple analysts have issued price targets for $ZION recently. We have seen 13 analysts offer price targets for $ZION in the last 6 months, with a median target of $63.0.
Here are some recent targets:
- David George from Baird set a target price of $65.0 on 10/17/2025
- Matthew Clark from Piper Sandler set a target price of $59.0 on 10/16/2025
- John Pancari from Evercore ISI Group set a target price of $64.0 on 09/30/2025
- Manan Gosalia from Morgan Stanley set a target price of $70.0 on 09/29/2025
- Janet Lee from TD Cowen set a target price of $64.0 on 09/25/2025
- Dave Rochester from Cantor Fitzgerald set a target price of $64.0 on 09/10/2025
- Jennifer Demba from Truist Securities set a target price of $59.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
